Clinical trial
Oral Positive Pressure Device (oPEP) Effect on Flow Pulsatility in the Fontan Circuit
NCT05634226 is registered in ClinicalTrials.gov with Tarek Alsaied as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oral Positive Pressure Device (oPEP) Effect on Flow Pulsatility in the Fontan Circuit
- Lead sponsor
- Tarek Alsaied
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 1, 2023
- Completion date
- January 31, 2024
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
single-ventricle